Association of Gender and Outcomes in Patients With Advanced NSCLC Treated With Immunotherapy Alone or in Combination With Chemotherapy Upfront

被引：0
|
作者：
Jimenez, J. Torres [1 ,2 ]
Gorria, T. [2 ]
Auclin, E. [3 ]
Castro, N. [4 ]
Albarran-Artahona, V. [2 ]
Ruffinelli, J. C. [5 ]
Pinato, D. [6 ]
Routy, B. [7 ]
Nana, F. Aboubakar
Reyes, R. [2 ]
Vinolas, N. [2 ,9 ]
Blanc-Durand, F. [8 ,10 ]
Lopes, G. [11 ]
Nadal, E. [12 ]
Arasanz, H. [4 ,13 ]
Pascal, M. [2 ,9 ]
Teixido, C. [2 ]
Besse, B. [10 ]
Reguart, N. [2 ,9 ]
Mezquita, L. [2 ,9 ]
Jimenez, J. Torres [1 ,2 ]
机构：
[1] Hosp Univ Ramon & Cajal, Madrid, Spain
[2] Hosp Clin Barcelona, Barcelona, Spain
[3] Univ Paris, Hop European George Pompidou, AP HP, Paris, France
[4] Hosp Univ Navarra, Pamplona, Spain
[5] Catalan Inst Oncol, Barcelona, Spain
[6] Hammersmith Hosp, Imperial Coll London, London, England
[7] Ctr Hosp Univ Montreal CHUM, Montreal, PQ, Canada
[8] Catholic Univ Louvain, Brussels, Belgium
[9] August Pi & Sunyer Biomed Res Inst IDIBAPS, Translat Genom & Targeted Therapeut Solid Tumor, Barcelona, Spain
[10] Gustave Roussy, Villejuif, France
[11] Univ Miami, Miami, FL USA
[12] Catalan Inst Oncol, Lhospitalet De Llobregat, Spain
[13] IdiSNA, Oncoimmunol Grp, Navarrabiomed, Pamplona, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
Gender; Immunotherapy alone; Immunotherapy combination with chemotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.01-09
引用
收藏
页码：S385 / S386
页数：2
相关论文
共 50 条
  • [31] Effect of Early Steroids use in Advanced NSCLC Patients Treated with Immunotherapy
    Fuca, G.
    Poggi, M.
    Galli, G.
    Imbimbo, M.
    Lo Russo, G.
    Proto, C.
    Vitali, M.
    Ganzinelli, M.
    Zilembo, N.
    De Braud, F.
    Garassino, M.
    Signorelli, D.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S390 - S390
  • [32] Sparing Treatment with Cytostatics for Patients with advanced NSCLC Dual Immunotherapy and Chemotherapy Combination is approved as First-line Therapy
    Ruedesheim, Sabine M.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (1-2) : 70 - 70
  • [33] Study compares upfront combination and sequential chemotherapy in patients with advanced nonresectable colorectal cancer
    不详
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 5 (06) : 663 - 663
  • [34] Combination of radiotherapy and chemotherapy in locally advanced NSCLC
    Kepka, Lucyna
    Sprawka, Arkadiusz
    Casas, Francesc
    Abdel-Wahab, Sherif
    Agarwal, Jai Prakash
    Jeremic, Branislav
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (10) : 1389 - 1403
  • [35] Baseline Tumor Size and Survival Outcomes among Patients with Advanced NSCLC treated with First-Line Immunotherapy
    Uehara, Y.
    Hakozaki, T.
    Kitadai, R.
    Hosomi, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S392 - S392
  • [36] Does Disease Burden on PET Predict Outcomes for Advanced NSCLC Patients Treated With First-Line Immunotherapy?
    Andraos, T. Y.
    Halmos, B.
    Cheng, H.
    Huntzinger, C.
    Shirvani, S.
    Ohri, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E428 - E428
  • [37] Comparison of Real-World Outcomes in aNSCLC Patients Receiving 1L Immunotherapy Alone or in Combination with Chemotherapy
    Lim, S. M.
    Jung, H. A.
    Lee, D. H.
    Lim, S.
    Lee, M. J.
    Yu, H.
    Yoon, S.
    Kim, K-P.
    Jeong, H.
    Kim, J.
    Zhao, X.
    Toh, K. C.
    Kim, D.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S637 - S637
  • [38] Role of the Neutrophil-Lymphocyte Elationship in Patients With Advanced NSCLC Treated With Immunotherapy
    Richardet, Eduardo
    Magi, I.
    Peruchin, V.
    Perea, P.
    Tello, A.
    Molina, M.
    Acosta, L.
    Paradelo, M.
    Richardet, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S12 - S12
  • [39] Tolerability and Treatment-Related Adverse Events of Upfront Pembrolizumab Combination Regimens in Advanced NSCLC Patients
    Jahan, N.
    Thein, K.
    Sultan, A.
    Swarup, S.
    Mogollon-Duffo, F.
    Adhikari, N.
    Arevalo, M.
    Htut, T.
    Naing, T.
    D'Cunha, N.
    Rehman, S.
    Hardwicke, F.
    Tijani, L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S726 - S726
  • [40] THE COMBINATION CHEMOTHERAPY OF CARBOPLATIN AND WEEKLY PACLITAXEL PLUS BEVACIZUMAB IN PATIENTS WITH ADVANCED NSCLC
    Kitaguchi, S.
    Kagawa, M.
    Yamaguchi, K.
    Watanabe, M.
    Ogawa, T.
    Furonaka, O.
    Sugahara, F.
    Egawa, H.
    ANNALS OF ONCOLOGY, 2013, 24
12345